Related Experiment Video
Updated: Jun 27, 2026

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
HENA, heterogeneous network-based data set for Alzheimer's disease
Elena Sügis1,2, Jerome Dauvillier3, Anna Leontjeva4
1Quretec Ltd., Ülikooli 6a, 51003, Tartu, Estonia.
This study introduces HENA, a novel data set for Alzheimer's disease research. HENA integrates diverse experimental data, enabling a comprehensive analysis of dementia mechanisms and potential drug targets.
Area of Science:
- Neuroscience
- Bioinformatics
- Genomics
Background:
- Alzheimer's disease (AD) and other dementias are leading causes of disability in older adults.
- Understanding AD's complex mechanisms requires integrating data from diverse scientific fields.
- Current data storage in separate databases hinders a holistic disease view.
Purpose of the Study:
- To introduce HENA (Heterogeneous network-based data set for Alzheimer's disease).
- To demonstrate the utility of graph convolutional networks (deep learning) for analyzing complex biological data.
- To provide a platform for scientists to contextualize their AD research findings.
Main Methods:
- Development of a heterogeneous network-based data set (HENA) for Alzheimer's disease.
- Application of graph convolutional networks (GCNs), a deep learning approach.
- Integration of data from proteomics, molecular biology, clinical diagnostics, and genomics.
Main Results:
- HENA successfully integrates diverse, complementary datasets for Alzheimer's disease research.
- Graph convolutional networks effectively analyze large, heterogeneous biological datasets.
- The study demonstrates a novel approach to systematically view AD data.
Conclusions:
- HENA offers a unified resource for Alzheimer's disease research.
- Deep learning methods, like GCNs, are powerful tools for analyzing integrated biological data.
- This approach facilitates a broader understanding of AD mechanisms and potential therapeutic targets.
More Related Videos
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
04:22Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles
Published on: May 20, 2024
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Dementia l: Introduction